Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium (MAPOCD)
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail
Sponsor: Pudong New Area People's Hospital
Listed as NCT02928692, this PHASE3 trial focuses on Carcinoma of the Rectum and Colon Cancer and remains ongoing. Sponsored by Pudong New Area People's Hospital, it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
▶ Show 3 earlier versions
-
Nov 2018 — Feb 2020 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pudong New Area People's Hospital
- RenJi Hospital
- Shanghai 10th People's Hospital
- Shanghai Pudong Hospital
- Shanghai Pudong New Aera Dongming Community Health Care Center
For direct contact, visit the study record on ClinicalTrials.gov .